치토젠엑스(CHNXF)는 OTCQB에 상장된 Healthcare · N/A 기업입니다. 현재가 $0.01 (+0.00%), 시가총액 $627,627, 52주 범위 $0.00 ~ $0.01.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
치토젠엑스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
일봉 종가 기준 계산값이며 과거 성과는 미래 수익을 보장하지 않습니다.
치토젠엑스의 현재 주가는 $0.01 (+0.00%)입니다. XTS에서 시세와 차트를 확인할 수 있습니다.
치토젠엑스의 시가총액은 약 $627,627입니다.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of…